Advancing mRNA as a therapeutic platform
ExploRNA Therapeutics develops next-generation mRNA therapeutics through innovations in mRNA cap analog chemistry. Spun out of the University of Warsaw, the company creates proprietary cap technologies—including AvantCap and ExploCap—that enhance mRNA stability and protein expression in vivo. ExploRNA partners with pharmaceutical companies to advance mRNA therapeutic platforms and programs across disease areas.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricing
